Borri Law Offices has filed the first claim brought in New Jersey against Biomet Orthopedics for a defective hip implant. The suit involves a defective metal-on-metal hip implant manufactured by Biomet called the Biomet® M2a-Magnum™ which was implanted in our client.
Our client experienced early failure of the hip implant, forcing her to undergo an additional risky and painful surgery to replace the defective Biomet hip implant. We have taken the first steps in obtaining legal compensation from the company which manufactured her defective device, Biomet, having filed a case on her behalf in New Jersey.
Our client is not the only victim of Biomet’s defective M2a-Magnum™ metal-on-metal hip replacement. In 2011, the Australian National Joint Registry found that the yearly cumulative revision rate for the Biomet® M2a-Magnum™ hip cup combined with a Biomet® M2a metal head was 7.2% after seven years. This rate is significantly higher than that associated with most competitor hip implant devices.
While metal-on-metal hip implants such as the Biomet® M2a-Magnum™ were marketed as long lasting devices, ideal for young and/ or active patients, the revision data and adverse effects reported tell a different story. Experts have found no advantage in metal-on-metal hip implants compared to hip implants with a different bearing type. Doctors have reported popping or squeaking noises, metal poisoning or metallosis, chronic pain, device loosening, pseudotumors and excess fluid in the hip capsule, among other symptoms of a failed metal-on-metal hip device in their patients with Biomet® M2a-Magnum™ hip replacements.